US Patent Issued to Five Prime Therapeutics on Nov. 11 for "Method of making afucosylated anti-FGFR2IIIB antibodies" (California Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,636, issued on Nov. 11, was assigned to Five Prime Therapeutics Inc. (Thousand Oaks, Calif.).

"Method of making afucosylated anti-FGFR2IIIB antibodies" was invented by Thomas Harding (San Francisco), Kristen Pierce (Burlingame, Calif.), Namrata Patil (Sunnyvale, Calif.), Thomas Brennan (San Jose, Calif.) and Julie Hambleton (San Francisco).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides antibodies that bind FGFR2IIIb, wherein the antibodies are afucosylated. The present invention provides compositions comprising antibodies that bind FGFR2IIIb, wherein at least 95% of the antibodies in the composition are afucosylated. In...